August 8, 2013

For traditional retail pharmacies, one of the biggest roadblocks to entry into the specialty arena is the limited availability of many complex medicines.

August 8, 2013

The world is turning generic. That's the takeaway from the latest trends in the drug industry, according to IMS Health.

August 8, 2013

By now, even a quick look at drug companies' product pipelines and patient demographics should make it clear that specialty drugs are where it's at.

August 8, 2013

The Supreme Court usually has a lot on its plate in any given year, but this year's term included a pretty big case for the pharmaceutical industry: the Federal Trade Commission v. Actavis, which concerned legal settlements between branded and generic drug makers that often occur when the latter attempts to market a generic drug before the former's patents have expired.

August 8, 2013

Despite significant challenges coming from private label, Procter & Gamble is still attempting to innovate the No. 1 brand in all of digestives — Prilosec OTC.

August 8, 2013

Pennsylvania last month became the 29th state to employ the National Precursor Log Exchange in the fight against the diversion of products containing pseudoephedrine into methamphetamine. State No. 30, Delaware, is expected to sign real-time stop sale technology into law this summer.

August 8, 2013

DSN has partnered with Competitive Promotion Report and IRI to create a new series of exclusive reports that analyzes the impact of trade promotion activity on various front-end merchandising categories — DSN Promo Watch.

August 7, 2013

Teva Women’s Health, the U.S subsidiary of Teva Pharmaceuticals, announced on Wednesday that the emergency contraceptive Plan B One-Step (levonorgestrel) tablet 1.5 mg is now widely available at retail with no age or point-of-sale restrictions.

August 6, 2013

The Food and Drug Administration has approved a generic heart disease drug made by Lupin, the Indian drug maker said.

August 6, 2013

Hospira posted sales of $1 billion during second quarter 2013, a 0.7% decrease compared with second quarter 2012, the generic drug maker said.

August 6, 2013

Mobile pharmacy technology company Mscripts has launched Web Pharmacy, which will allow pharmacies to offer patients an integrated and branded web and mobile environment to manage their health and prescription needs, the company said Tuesday.

August 6, 2013

“We're asking the pharmacists to be proactive in their communication rather than reactive.”

That’s Andrew Markievich, manager of pharmacy clinical programs for Ahold USA, the big Dutch-based owner-operator of U.S. supermarket chains like Stop & Shop and Giant Food in the Northeast and mid-Atlantic region. Speaking to Drug Store News’ Alaric DeArment, Markievich was describing a new campaign at Ahold USA’s more than 560 food-store pharmacies “to take a more active, deliberate role in communicating with our patients.”

August 6, 2013

Canadian pharmacy retailer Rexall has announced the launch of MyRexall, providing its customers with the ability to view and print their personal medication records online at Rexall.ca.

August 5, 2013

Express Scripts and Walgreens last week announced the launch of Smart90 Walgreens, a new option for Express Scripts clients interested in 90-day prescription drug programs and to help drive lower costs. The program is expected to improve medication adherence by both providing a cost value to the patient while maintaining what has more and more become a crucial patient-pharmacist face-to-face encounter.

What a difference a year makes. Far removed from its squabbles over reimubursement, the two companies partner on a new program that reinforces the value that retail pharmacy provides and the innovative ways that retail and mail can work together to create solutions that help get patients on, and keep them on, their medications.

August 5, 2013

Softlips lip balm announced the company will offer an innovative twist on lip hydration with the brand's latest portfolio addition.

August 2, 2013

The Senate was expected to take up a bill designed to secure the drug supply chain and establish a list of "do not compound" medications, but left for recess Friday without voting on it.

August 1, 2013

A new app allows patients to communicate through audio and video with their pharmacies using a smartphone, tablet or computer.

August 1, 2013

Sanofi Wednesday evening announced that the Food and Drug Administration's Nonprescription Drugs Advisory Committee voted 10-6 in favor of its switch application of the nasal corticosteroid Nasacort AQ. Two committee members abstained.

August 1, 2013

Emdeon has given pharmacy automation products maker QS/1 certification for electronic prescriptions of controlled substances, or EPCS, QS/1 said Thursday.

August 1, 2013

Express Scripts and Walgreens announced the launch of Smart90 Walgreens, a new option for Express Scripts clients interested in 90-day prescription drug programs that helps drive lower costs.

July 31, 2013

The Food and Drug Administration has approved a Perrigo generic drug for treating dermatitis, the company said Wednesday.

July 31, 2013

The Food and Drug Administration has given Lupin Pharmaceuticals tentative approval to two of its products, the company said Wednesday.

July 31, 2013

Nearly 450 drugs are under development for treating neurological disorders, according to a report by a drug industry trade group.

July 30, 2013

Big data finds another application and another supporter. Sort of.

The full Senate will shortly take up a new track-and-trace bill (S. 959), which would establish a national system for tracking the pedigree and movement of most pharmaceuticals, from point of manufacture and distribution to the dispensing pharmacy and the patient at the end of the supply chain. The goal: to replace the hodge-podge of different state laws with a single, nationwide track-and-trace system capable of capturing the daily flood of drug production, distribution, dispensing and utilization data and channeling it into an accessible tool by which stakeholders and regulators could secure the pharmaceutical supply chain.